Anticalin(®) Proteins as Therapeutic Agents in Human Diseases

Anticalin proteins are an emerging class of clinical-stage biopharmaceuticals with high potential as an alternative to antibodies. Anticalin molecules are generated by combinatorial design from natural lipocalins, which are abundant plasma proteins in humans, and reveal a simple, compact fold domina...

Descripción completa

Detalles Bibliográficos
Autores principales: Rothe, Christine, Skerra, Arne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990566/
https://www.ncbi.nlm.nih.gov/pubmed/29748739
http://dx.doi.org/10.1007/s40259-018-0278-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990566/
https://www.ncbi.nlm.nih.gov/pubmed/29748739
http://dx.doi.org/10.1007/s40259-018-0278-1

Ejemplares similares